Coumarin– and Dipicolylamine–Terpenoid Hybrids as Selective Carbonic Anhydrases IX and XII Inhibitors: Mechanistic Insights and Selective Anti-Cancer Potential
Pharmaceuticals · 30.04.2026 · 19 (5) · 717
DOI: 10.3390/ph19050717 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 30.04.2026. Verfasst von Venkatesan Saravanan und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, SBV Chennai, Sri Balaji Vidyapeeth, Pondicherry 607402, India. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of University and Research, Italian Association for Cancer Research, PRIN PNRR.
Abstract (Originalsprache)
Background
Carbonic Anhydrases (CAs) represent regulators of cell adaptation to hypoxia, pH regulation, and metabolic fitness. Among cancers, multiple myeloma (MM) is a plasma cell malignancy sustained by hypoxia-driven metabolic adaptation, extracellular acidification, and redox imbalance. Tight regulation of tumor extracellular pH, mediated by Carbonic Anhydrases IX and XII, is crucial for myeloma survival, progression, and stemness, making these isoforms attractive therapeutic targets.
Methods
We designed and synthesized a library of terpenoid-based hybrids by derivatizing chlorothymol and 4-isopropyl-3-methylphenol with either the natural coumarin umbelliferon or the 2,2′-dipicolylamine (DPA) scaffold. This chemical strategy aimed to selectively inhibit tumor-associated CAs IX/XII through coumarin- or DPA-mediated recognition, while terpenoid fragments were introduced to enhance lipophilicity, membrane permeability, and potential redox-modulating properties. The compounds were tested by a Stopped-Flow assay for CA inhibition, in cell-based assays for antiproliferative properties and by means of several antioxidant assays.
Results
The most active compounds, connecting the coumarin core to a terpenoid tail, inhibited the targeted CAs in the nanomolar range, showing up higher selectivity over off-target isoforms (I and II). In studies performed on MM cell lines, selected derivatives reduced viability (IC50 = 15.8–85.4 µM) and displayed favorable selectivity over normal cells. In silico investigations suggested that the compounds were able to interact selectively with the target enzymes.
Conclusions
Collectively, these results support a dual-targeting strategy in which selective inhibition of tumor-associated CAs, combined with redox modulation, interferes with adaptive mechanisms of MM cells, providing a rational framework for the development of multifunctional agents against metabolically resilient hematological malignancies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmacy, SBV Chennai, Sri Balaji Vidyapeeth, Pondicherry 607402, India.
- Neurofarba Department, University of Florence, Sesto Fiorentino, 50019 Florence, Italy.
- Department of Pharmacy, "G. d'Annunzio" University of Chieti-Pescara, 66100 Chieti, Italy.
- Department of Experimental and Clinical Medicine, University "Magna Græcia" of Catanzaro, Campus "S. Venuta", 88100 Catanzaro, Italy.
- Department of Pharmacy, Health and Nutritional Science, University of Calabria, 87036 Rende, Italy.
- Department of Pharmacy, University of Pisa, via Bonanno Pisano 6, 56126 Pisa, Italy.
ORCID-Profile: Andrea Angeli, Francesco Melfi, Ilenia Valentino, Ilaria D'Agostino, Kathiravan Muthukumaradoss, Gokhan Zengin, Davide Moi, Claudiu T Supuran, Simone Carradori
Förderung
- Italian Ministry of University and Research
- Italian Association for Cancer Research
- PRIN PNRR
Zitieren
APA
Saravanan, V., Angeli, A., Melfi, F., Amodio, N., Valentino, I., Gentile, M., D'Agostino, I., Muthukumaradoss, K., Zengin, G., Moi, D., Simsek, R., Supuran, C. T., & Carradori, S. (2026). Coumarin– and Dipicolylamine–Terpenoid Hybrids as Selective Carbonic Anhydrases IX and XII Inhibitors: Mechanistic Insights and Selective Anti-Cancer Potential. Pharmaceuticals, 19(5), 717. https://doi.org/10.3390/ph19050717
Vancouver
Saravanan V, Angeli A, Melfi F, Amodio N, Valentino I, Gentile M, et al. Coumarin– and Dipicolylamine–Terpenoid Hybrids as Selective Carbonic Anhydrases IX and XII Inhibitors: Mechanistic Insights and Selective Anti-Cancer Potential. Pharmaceuticals. 2026;19(5):717. doi:10.3390/ph19050717
BibTeX
@article{Saravanan2026,
author = {Saravanan, Venkatesan and Angeli, Andrea and Melfi, Francesco and Amodio, Nicola and Valentino, Ilenia and Gentile, Massimo and D'Agostino, Ilaria and Muthukumaradoss, Kathiravan and Zengin, Gokhan and Moi, Davide and Simsek, Rahime and Supuran, Claudiu T and Carradori, Simone},
title = {Coumarin– and Dipicolylamine–Terpenoid Hybrids as Selective Carbonic Anhydrases IX and XII Inhibitors: Mechanistic Insights and Selective Anti-Cancer Potential},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {5},
pages = {717},
doi = {10.3390/ph19050717}
}
EUVIMED